Immunology Of Pediatric HIV Infection

Immunological Reviews

Volumn 254, Issue 1, 2013, Pages 143-169

  Tobin, Nicole H ^a   Aldrovandi, Grace M ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Breast milk; Children; Gut microbiota; HIV; Neonatal; Regulatory T cells; Th17

Indexed keywords

CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 7; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; BREAST MILK; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGY; IMMUNOMODULATION; INFECTION PREVENTION; PLACENTAL TRANSFER; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SEXUAL TRANSMISSION; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84879314496     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12074     Document Type: Article

References (372)

1. The Working Group on Mother-To-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:506-510.
2. Taha TE, et al. Association of recent HIV infection and in-utero HIV-1 transmission. AIDS 2011;25:1357-1364.
3. Aldrovandi GM, Kuhn L. What infants and breasts can teach us about natural protection from HIV infection. J Infect Dis 2010;202(Suppl):S366-370.
4. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004;291:1127-1131.
5. Lee TH, Chafets DM, Biggar RJ, McCune JM, Busch MP. The role of transplacental microtransfusions of maternal lymphocytes in in utero HIV transmission. J Acquir Immune Defic Syndr 2010;55:143-147.
6. Biggar RJ, et al. The role of transplacental microtransfusions of maternal lymphocytes in HIV transmission to newborns. AIDS 2008;22:2251-2256.
7. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990;61:213-222.
8. Mold JE, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008;322:1562-1565.
9. Flanagan KL, et al. The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth. Eur J Immunol 2010;40:1062-1072.
10. Legrand FA, et al. Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS ONE 2006;1:e102.
11. Kumar SB, et al. Elevated cytokine and chemokine levels in the placenta are associated with in-utero HIV-1 mother-to-child transmission. AIDS 2012;26:685-694.
12. Mwanyumba F, et al. Placental inflammation and perinatal transmission of HIV-1. J Acquir Immune Defic Syndr 2002;29:262-269.
13. St LM, et al. Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. JAMA 1993;269:2853-2859.
14. Wabwire-Mangen F, et al. Placental membrane inflammation and risks of maternal-to-child transmission of HIV-1 in Uganda. J Acquir Immune Defic Syndr 1999;22:379-385.
15. Bunders MJ, et al. Memory CD4(+)CCR5(+) T cells are abundantly present in the gut of newborn infants to facilitate mother-to-child transmission of HIV-1. Blood 2012;120:4383-4390.
16. Ho WZ, Lioy J, Song L, Cutilli JR, Polin RA, Douglas SD. Infection of cord blood monocyte-derived macrophages with human immunodeficiency virus type 1. J Virol 1992;66:573-579.
17. Reinhardt PP, Reinhardt B, Lathey JL, Spector SA. Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates. J Clin Microbiol 1995;33:292-297.
18. Sundaravaradan V, Saxena SK, Ramakrishnan R, Yedavalli VR, Harris DT, Ahmad N. Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression. Proc Natl Acad Sci USA 2006;103:11701-11706.
19. Tugizov SM, et al. Differential transmission of HIV traversing fetal oral/intestinal epithelia and adult oral epithelia. J Virol 2012;86:2556-2570.
20. Joubert BR, Franceschini N, Mwapasa V, North KE, Meshnick SR. Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi. PLoS ONE 2010;5:e9212.
21. Aguilar-Jimenez W, Zapata W, Rugeles MT. Differential expression of human beta defensins in placenta and detection of allelic variants in the DEFB1 gene from HIV-1 positive mothers. Biomedica 2011;31:44-54.
22. Patterson BK, et al. Leukemia inhibitory factor inhibits HIV-1 replication and is upregulated in placentae from nontransmitting women. J Clin Invest 2001;107:287-294.
23. Johnson EL, Chakraborty R. Placental Hofbauer cells limit HIV-1 replication and potentially offset mother to child transmission (MTCT) by induction of immunoregulatory cytokines. Retrovirology 2012;9:101.
24. Marlin R, et al. Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interface. Retrovirology 2011;8:58.
25. European Mode of Delivery Collaboration . Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999;353:1035-1039.
26. Mandelbrot L, et al. Frequent detection of HIV-1 in the gastric aspirates of neonates born to HIV-infected mothers. AIDS 1999;13:2143-2149.
27. Stiehm ER, et al. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185. J Infect Dis 1999;179:567-575.
28. Zinkernagel RM. Maternal antibodies, childhood infections, and autoimmune diseases. N Engl J Med 2001;345:1331-1335.
29. Siegrist CA. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003;21:3406-3412.
30. Hessell AJ, et al. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques. Nat Med 2009;15:951-954.
31. Hessell AJ, et al. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog 2009;5:e1000433.
32. Ng CT, et al. Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nat Med 2010;16:1117-1119.
33. Nishimura Y, et al. Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J Virol 2002;76:2123-2130.
34. Parren PW, et al. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro. J Virol 2001;75:8340-8347.
35. Lewis P, et al. Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis 1998;177:34-39.
36. Heath L, et al. Restriction of HIV-1 genotypes in breast milk does not account for the population transmission genetic bottleneck that occurs following transmission. PLoS ONE 2010;5:e10213.
37. Semrau K, et al. Temporal and lateral dynamics of HIV shedding and elevated sodium in breast milk among HIV-positive mothers during the first 4 months of breast-feeding. J Acquir Immune Defic Syndr 2008;47:320-328.
38. Thea DM, et al. Post-weaning breast milk HIV-1 viral load, blood prolactin levels and breast milk volume. AIDS 2006;20:1539-1547.
39. Kantarci S, Koulinska IN, Aboud S, Fawzi WW, Villamor E. Subclinical mastitis, cell-associated HIV-1 shedding in breast milk, and breast-feeding transmission of HIV-1. J Acquir Immune Defic Syndr 2007;46:651-654.
40. Kuhn L, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 2008;359:130-141.
41. Semrau K, et al. Dynamics of breast milk HIV-1 RNA with unilateral mastitis or abscess. J Acquir Immune Defic Syndr 2013;62:348-355.
42. Gray RR, et al. Multiple independent lineages of HIV-1 persist in breast milk and plasma. AIDS 2011;25:143-152.
43. Gantt S, et al. Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis. J Virol 2010;84:10812-10819.
44. Salazar-Gonzalez JF, et al. Origin and evolution of HIV-1 in breast milk determined by single-genome amplification and sequencing. J Virol 2011;85:2751-2763.
45. Gray L, Fiscus S, Shugars D. HIV-1 variants from a perinatal transmission pair demonstrate similar genetic and replicative properties in tonsillar tissues and peripheral blood mononuclear cells. AIDS Res Hum Retroviruses 2007;23:1095-1104.
46. Becquart P, Hocini H, Garin B, Sepou A, Kazatchkine MD, Belec L. Compartmentalization of the IgG immune response to HIV-1 in breast milk. AIDS 1999;13:1323-1331.
47. Bulek K, Swaidani S, Aronica M, Li X. Epithelium: the interplay between innate and Th2 immunity. Immunol Cell Biol 2010;88:257-268.
48. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group. Lancet 1999;354:471-476.
49. Kuhn L, et al. High uptake of exclusive breastfeeding and reduced early post-natal HIV transmission. PLoS ONE 2007;2:e1363.
50. Iliff PJ, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 2005;19:699-708.
51. Coovadia HM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007;369:1107-1116.
52. Piwoz EG, et al. The impact of safer breastfeeding practices on postnatal HIV-1 transmission in Zimbabwe. Am J Pub Health 2007;97:1249-1254.
53. Lunney KM, et al. Associations between breast milk viral load, mastitis, exclusive breast-feeding, and postnatal transmission of HIV. Clin Infect Dis 2010;50:762-769.
54. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Lancet 2000;355:451-455.
55. Victora CG, et al. Evidence for protection by breast-feeding against infant deaths from infectious diseases in Brazil. Lancet 1987;2:319-322.
56. Brown KH, Black RE, Lopez de Romana G, Creed de Kanashiro H. Infant-feeding practices and their relationship with diarrheal and other diseases in Huascar (Lima), Peru. Pediatrics 1989;83:31-40.
57. Semrau K, et al. Exclusive breastfeeding, maternal HIV disease, and the risk of clinical breast pathology in HIV-infected, breastfeeding women. Am J Obstet Gynecol 2011;205:344 e341-348.
58. Semba RD, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999;180:93-98.
59. Embree JE, et al. Risk factors for postnatal mother-child transmission of HIV-1. AIDS 2000;14:2535-2541.
60. John GC, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 2001;183:206-212.
61. Fawzi W, et al. Transmission of HIV-1 through breastfeeding among women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr 2002;31:331-338.
62. Lyimo MA, et al. Breast milk from Tanzanian women has divergent effects on cell-free and cell-associated HIV-1 infection in vitro. PLoS ONE 2012;7:e43815.
63. Farquhar C, et al. CC and CXC chemokines in breastmilk are associated with mother-to-child HIV-1 transmission. Curr HIV Res 2005;3:361-369.
64. Bosire R, et al. Longitudinal comparison of chemokines in breastmilk early postpartum among HIV-1-infected and uninfected Kenyan women. Breastfeeding Med 2007;2:129-138.
65. Lohman-Payne B, et al. Breast milk cellular HIV-specific interferon gamma responses are associated with protection from peripartum HIV transmission. AIDS 2012;26:2007-2016.
66. Martin V, Maldonado A, Fernandez L, Rodriguez JM, Connor RI. Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk. Breastfeeding Med 2010;5:153-158.
67. Naarding MA, et al. Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells. Antimicrob Agents Chemother 2006;50:3367-3374.
68. Walter J, et al. High concentrations of interleukin 15 in breast milk are associated with protection against postnatal HIV transmission. J Infect Dis 2009;200:1498-1502.
69. Walter J, et al. Low and undetectable breast milk interleukin-7 concentrations are associated with reduced risk of postnatal HIV transmission. J Acquir Immune Defic Syndr 2007;46:200-207.
70. Kuhn L, et al. Alpha-defensins in the prevention of HIV transmission among breastfed infants. J Acquir Immune Defic Syndr 2005;39:138-142.
71. Bosire R, et al. Breast milk alpha-defensins are associated with HIV type 1 RNA and CC chemokines in breast milk but not vertical HIV type 1 transmission. AIDS Res Hum Retroviruses 2007;23:198-203.
72. Villamor E, et al. Long-chain n-6 polyunsaturated fatty acids in breast milk decrease the risk of HIV transmission through breastfeeding. Am J Clin Nutr 2007;86:682-689.
73. Bode L, et al. Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding. Am J Clin Nutr 2012;96:831-839.
74. Arsenault JE, Webb AL, Koulinska IN, Aboud S, Fawzi WW, Villamor E. Association between breast milk erythropoietin and reduced risk of mother-to-child transmission of HIV. J Infect Dis 2010;202:370-373.
75. Kuhn L, et al. Hiv-specific secretory IgA in breast milk of HIV-positive mothers is not associated with protection against HIV transmission among breast-fed infants. J Ped 2006;149:611-616.
76. Mabuka J, Nduati R, Odem-Davis K, Peterson D, Overbaugh J. HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads. PLoS Pathog 2012;8:e1002739.
77. Walter J, Kuhn L, Aldrovandi GM. Advances in basic science understanding of mother-to-child HIV-1 transmission. Curr Opin HIV AIDS 2008;3:146-150.
78. Lehman DA, Farquhar C. Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 2007;17:381-403.
79. Naarding MA, et al. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest 2005;115:3256-3264.
80. Saeland E, de Jong MA, Nabatov AA, Kalay H, Geijtenbeek TB, van Kooyk Y. MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol Immunol 2009;46:2309-2316.
81. Hong P, Ninonuevo MR, Lee B, Lebrilla C, Bode L. Human milk oligosaccharides reduce HIV-1-gp120 binding to dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN). Br J Nutr 2009;101:482-486.
82. Ruben FL, Holzman IR, Fireman P. Responses of lymphocytes from human colostrum or milk to influenza antigens. Am J Obstet Gynecol 1982;143:518-522.
83. Scott R, Scott M, Toms GL. Cellular reactivity to respiratory syncytial virus in human colostrum and breast milk. J Med Virol 1985;17:83-93.
84. Sabbaj S, et al. Human immunodeficiency virus-specific CD8(+) T cells in human breast milk. J Virol 2002;76:7365-7373.
85. Bertotto A, et al. Human breast milk T lymphocytes display the phenotype and functional characteristics of memory T cells. Eur J Immunol 1990;20:1877-1880.
86. Sabbaj S, Ibegbu CC, Kourtis AP. Cellular immunity in breast milk: implications for postnatal transmission of HIV-1 to the infant. Adv Exp Med Biol 2012;743:161-169.
87. Sabbaj S, et al. Breast milk-derived antigen-specific CD8+ T cells: an extralymphoid effector memory cell population in humans. J Immunol 2005;174:2951-2956.
88. Jain L, Vidyasagar D, Xanthou M, Ghai V, Shimada S, Blend M. In vivo distribution of human milk leucocytes after ingestion by newborn baboons. Arch Dis Childhood 1989;64:930-933.
89. Schnorr KL, Pearson LD. Intestinal absorption of maternal leucocytes by newborn lambs. J Repro Immunol 1984;6:329-337.
90. Head JR, Beer AE, Billingham RE. Significance of the cellular component of the maternal immunologic endowment in milk. Transplant Proc 1977;9:1465-1471.
91. Weiler IJ, Hickler W, Sprenger R. Demonstration that milk cells invade the suckling neonatal mouse. Am J Repro Immunol 1983;4:95-98.
92. Zhou L, et al. Two independent pathways of maternal cell transmission to offspring: through placenta during pregnancy and by breast-feeding after birth. Immunology 2000;101:570-580.
93. Ranganathan UD, Larsen MH, Kim J, Porcelli SA, Jacobs WR Jr, Fennelly GJ. Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice. Vaccine 2009;28:152-161.
94. Mahlokozera T, et al. The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk. PLoS ONE 2011;6:e23735.
95. Belec L, Kourtis AP. B lymphocyte-derived humoral immune defenses in breast milk transmission of the HIV-1. Adv Exp Med Biol 2012;743:139-160.
96. Lallemant M, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000;343:982-991.
97. Marinda E, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Ped Infec Dis J 2007;26:519-526.
98. Fawzi W, et al. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. AIDS 2001;15:1157-1165.
99. Becquet R, et al. Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: a meta-analysis. PLoS ONE 2012;7:e28510.
100. European Collaborative Study. Level and pattern of HIV-1-RNA viral load over age: differences between girls and boys? AIDS 2002;16:97-104.
101. Dunn D. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 2003;362:1605-1611.
102. McIntosh K, et al. Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus. Ped Infect Dis J 1996;15:1087-1091.
103. HIV Paediatric Prognostic Markers Collaborative Study 2013, Available from http://www.hppmcs.org/ (Accessed 30 January 2013).
104. Sperduto AR, Bryson YJ, Chen IS. Increased susceptibility of neonatal monocyte/macrophages to HIV-1 infection. AIDS Res Hum Retroviruses 1993;9:1277-1285.
105. Pillay T, et al. Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection. J Virol 2005;79:12100-12105.
106. Thobakgale CF, et al. Impact of HLA in mother and child on disease progression of pediatric human immunodeficiency virus type 1 infection. J Virol 2009;83:10234-10244.
107. Dunn D, et al. Current CD4 cell count and the short-term risk of AIDS and death before the availability of effective antiretroviral therapy in HIV-infected children and adults. J Infect Dis 2008;197:398-404.
108. Sanchez-Schmitz G, Levy O. Development of newborn and infant vaccines. Sci Trans Med 2011;3:90 ps27..
109. Haynes BF, Heinly CS. Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J Exp Med 1995;181:1445-1458.
110. Lewis DB, Wilson CB. Developmental Immunology and Role of Host Defenses in Fetal and Neonatal Susceptibility to Infection. 7th edn. Philadelphia: WB Saunders, 2011.
111. Corbett NP, et al. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS ONE 2010;5:e15041.
112. Nguyen M, et al. Acquisition of adult-like TLR4 and TLR9 responses during the first year of life. PLoS ONE 2010;5:e10407.
113. Burl S, et al. Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. PLoS ONE 2011;6:e18185.
114. Belderbos ME, Levy O, Stalpers F, Kimpen JL, Meyaard L, Bont L. Neonatal plasma polarizes TLR4-mediated cytokine responses towards low IL-12p70 and high IL-10 production via distinct factors. PLoS ONE 2012;7:e33419.
115. Levy O, Coughlin M, Cronstein BN, Roy RM, Desai A, Wessels MR. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J Immunol 2006;177:1956-1966.
116. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7:379-390.
117. Levy O. Innate immunity of the human newborn: distinct cytokine responses to LPS and other Toll-like receptor agonists. J Endotoxin Res 2005;11:113-116.
118. Belderbos ME, et al. Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life. Clin Immunol 2009;133:228-237.
119. Rose S, Lichtenheld M, Foote MR, Adkins B. Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. J Immunol 2007;178:2667-2678.
120. Webster RB, Rodriguez Y, Klimecki WT, Vercelli D. The human IL-13 locus in neonatal CD4+ T cells is refractory to the acquisition of a repressive chromatin architecture. J Biol Chem 2007;282:700-709.
121. Weitzel RP, et al. microRNA 184 regulates expression of NFAT1 in umbilical cord blood CD4+ T cells. Blood 2009;113:6648-6657.
122. Adkins B, Leclerc C, Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004;4:553-564.
123. Haines CJ, et al. Human CD4+ T cell recent thymic emigrants are identified by protein tyrosine kinase 7 and have reduced immune function. J Exp Med 2009;206:275-285.
124. Grindebacke H, et al. Dynamic development of homing receptor expression and memory cell differentiation of infant CD4+CD25high regulatory T cells. J Immunol 2009;183:4360-4370.
125. Mold JE, et al. Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science 2010;330:1695-1699.
126. Ivanov II, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139:485-498.
127. Ivanov II, Littman DR. Segmented filamentous bacteria take the stage. Mucosal Immunol 2010;3:209-212.
128. Ivanov II, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008;4:337-349.
129. Gaboriau-Routhiau V, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 2009;31:677-689.
130. Brenchley JM, et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008;112:2826-2835.
131. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012;30:531-564.
132. Murai M, Krause P, Cheroutre H, Kronenberg M. Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol 2010;3:443-449.
133. Black A, Bhaumik S, Kirkman RL, Weaver CT, Randolph DA. Developmental regulation of Th17-cell capacity in human neonates. Eur J Immunol 2012;42:311-319.
134. Siegrist CA, Aspinall R. B-cell responses to vaccination at the extremes of age. Nat Rev Immunol 2009;9:185-194.
135. Shearer WT, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol 2003;112:973-980.
136. Schatorje EJ, Gemen EF, Driessen GJ, Leuvenink J, van Hout RW, de Vries E. Paediatric reference values for the peripheral T cell compartment. Scan J Immunol 2012;75:436-444.
137. Krogstad P, Uittenbogaart CH, Dickover R, Bryson YJ, Plaeger S, Garfinkel A. Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics. Clin Immunol 1999;92:25-33.
138. Stiehm ER, Fudenberg HH. Serum levels of immune globulins in health and disease: a survey. Pediatrics 1966;37:715-727.
139. Mastelic B, et al. Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants. J Immunol 2012;189:5764-5772.
140. Lundell AC, et al. Infant B cell memory differentiation and early gut bacterial colonization. J Immunol 2012;188:4315-4322.
141. Saxonhouse MA, Sleasman J. Immunodeficiency diseases of the neonate. In: Alarcon D ed. Neonatal Hemotolgy. Cambridge: Cambridge University Press, 2009:280-309.
142. Marchant A, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination. J Immunol 1999;163:2249-2255.
143. Marchant A, et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 2003;111:1747-1755.
144. Marchant A, Goldman M. T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol 2005;141:10-18.
145. Kollmann TR, et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J Immunol 2009;183:7150-7160.
146. Prendergast AJ, Klenerman P, Goulder PJ. The impact of differential antiviral immunity in children and adults. Nat Rev Immunol 2012;12:636-648.
147. Insoft RM, Sanderson IR, Walker WA. Development of immune function in the intestine and its role in neonatal diseases. Ped Clin N Am 1996;43:551-571.
148. Grdic D, Hornquist E, Kjerrulf M, Lycke NY. Lack of local suppression in orally tolerant CD8-deficient mice reveals a critical regulatory role of CD8+ T cells in the normal gut mucosa. J Immunol 1998;160:754-762.
149. Nanthakumar N, et al. The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS ONE 2011;6:e17776.
150. Claud EC, Lu L, Anton PM, Savidge T, Walker WA, Cherayil BJ. Developmentally regulated IkappaB expression in intestinal epithelium and susceptibility to flagellin-induced inflammation. Proc Natl Acad Sci USA 2004;101:7404-7408.
151. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364:255-264.
152. Brandtzaeg PE. Current understanding of gastrointestinal immunoregulation and its relation to food allergy. Ann NY Acad Sci 2002;964:13-45.
153. Paiardini M, Frank I, Pandrea I, Apetrei C, Silvestri G. Mucosal immune dysfunction in AIDS pathogenesis. AIDS Rev 2008;10:36-46.
154. Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annu Rev Immunol 2012;30:149-173.
155. Marchetti G, Tincati C, Silvestri G. Microbial Translocation in the Pathogenesis of HIV Infection and AIDS. Clin Microbiol Rev 2013;26:2-18.
156. Dominguez-Bello MG, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010;107:11971-11975.
157. Gronlund MM, Lehtonen OP, Eerola E, Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Ped Gastroenterol Nutr 1999;28:19-25.
158. Adlerberth I, et al. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle? Ped Res 2006;59:96-101.
159. Neu J, Rushing J. Cesarean versus vaginal delivery: long-term infant outcomes and the hygiene hypothesis. Clin Perinatol 2011;38:321-331.
160. Koenig JE, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011;108(Suppl):4578-4585.
161. Yatsunenko T, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222-227.
162. Renz H, Brandtzaeg P, Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 2012;12:9-23.
163. Cornes JS. Number, size, and distribution of Peyer's patches in the human small intestine: Part I The development of Peyer's patches. Gut 1965;6:225-229.
164. Gronlund MM, Arvilommi H, Kero P, Lehtonen OP, Isolauri E. Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months. Arch Dis Childhood Fetal Neonatal Ed 2000;83:F186-192.
165. Sjogren YM, et al. Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses. Clin Exp Allergy 2009;39:1842-1851.
166. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010;107:12204-12209.
167. Schwartz S, et al. A metagenomic study of diet-dependent interaction between gut microbiota and host in infants reveals differences in immune response. Genome Biol 2012;13:r32.
168. Perez PF, et al. Bacterial imprinting of the neonatal immune system: lessons from maternal cells? Pediatrics 2007;119:e724-732.
169. Hunt KM, et al. Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS ONE 2011;6:e21313.
170. Isaacs CE. Human milk inactivates pathogens individually, additively, and synergistically. J Nutr 2005;135:1286-1288.
171. Marcobal A, Sonnenburg JL. Human milk oligosaccharide consumption by intestinal microbiota. Clin Microbiol Infect 2012;18(Suppl):12-15.
172. Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012;22:1147-1162.
173. Ganguli K, Meng D, Rautava S, Lu L, Walker WA, Nanthakumar N. Probiotics prevent necrotizing enterocolitis by modulating enterocyte genes that regulate innate immune-mediated inflammation. Am J Physiol Gastrointest Liver Physiol 2013;304:G132-141.
174. Ganguli K, Walker WA. Treatment of necrotizing enterocolitis with probiotics. Gastroenterol Clin N Am 2012;41:733-746.
175. Section on Breastfeeding . Breastfeeding and the use of human milk. Pediatrics 2012;129:e827-841.
176. Mata LJ, Urrutia JJ, Garcia B, Fernandez R, Behar M. Shigella infection in breast-fed Guatemalan indian neonates. Am J Dis Child 1969;117:142-146.
177. Newburg DS, Ashkenazi S, Cleary TG. Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3. J Infect Dis 1992;166:832-836.
178. Jantscher-Krenn E, et al. The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut 2012;61:1417-1425.
179. Brandtzaeg P. The gut as communicator between environment and host: immunological consequences. Eur J Pharmacol 2011;668(Suppl):S16-32.
180. Catassi C, Bonucci A, Coppa GV, Carlucci A, Giorgi PL. Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J Ped Gastroenterol Nutr 1995;21:383-386.
181. Boirivant M, et al. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis. Gastroenterology 2008;135:1612-1623. e1615.
182. Lefevre CM, Sharp JA, Nicholas KR. Evolution of lactation: ancient origin and extreme adaptations of the lactation system. Annu Rev Genomics Hum Genet 2010;11:219-238.
183. Vorbach C, Capecchi MR, Penninger JM. Evolution of the mammary gland from the innate immune system? BioEssays 2006;28:606-616.
184. McClellan HL, Miller SJ, Hartmann PE. Evolution of lactation: nutrition v. protection with special reference to five mammalian species. Nutr Res Rev 2008;21:97-116.
185. Brandtzaeg P. Mucosal immunity: integration between mother and the breast-fed infant. Vaccine 2003;21:3382-3388.
186. Quigley MA, Kelly YJ, Sacker A. Breastfeeding and hospitalization for diarrheal and respiratory infection in the United Kingdom Millennium Cohort Study. Pediatrics 2007;119:e837-842.
187. Lawrence RM, Pane CA. Human breast milk: current concepts of immunology and infectious diseases. Curr Prob Ped Adolesc Health Care 2007;37:7-36.
188. Labbok MH, Clark D, Goldman AS. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol 2004;4:565-572.
189. Iyengar SR, Walker WA. Immune factors in breast milk and the development of atopic disease. J Ped Gastro Nutr 2012;55:641-647.
190. Shulzhenko N, et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat Med 2011;17:1585-1593.
191. Hamosh M, et al. Protective function of human milk: the milk fat globule. Semin Perinatol 1999;23:242-249.
192. Silfverdal SA, Ekholm L, Bodin L. Breastfeeding enhances the antibody response to Hib and Pneumococcal serotype 6B and 14 after vaccination with conjugate vaccines. Vaccine 2007;25:1497-1502.
193. Ngom PT, Collinson AC, Pido-Lopez J, Henson SM, Prentice AM, Aspinall R. Improved thymic function in exclusively breastfed infants is associated with higher interleukin 7 concentrations in their mothers' breast milk. Am J Clin Nutr 2004;80:722-728.
194. Aspinall R, Prentice AM, Ngom PT. Interleukin 7 from maternal milk crosses the intestinal barrier and modulates T-cell development in offspring. PLoS ONE 2011;6:e20812.
195. Lack G. The concept of oral tolerance induction to foods. Nestle Nutr Workshop Ser Paediatr Program 2007;59:63-68; discussion 68-72.
196. Garofalo RP, Goldman AS. Expression of functional immunomodulatory and anti-inflammatory factors in human milk. Clin Perinatol 1999;26:361-377.
197. Gottrand F. Long-chain polyunsaturated fatty acids influence the immune system of infants. J Nutr 2008;138:1807S-1812S.
198. Gdalevich M, Mimouni D, David M, Mimouni M. Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. J Am Acad Dermatol 2001;45:520-527.
199. Kull I, Wickman M, Lilja G, Nordvall SL, Pershagen G. Breast feeding and allergic diseases in infants-a prospective birth cohort study. Arch Dis Childhood 2002;87:478-481.
200. Mimouni Bloch A, Mimouni D, Mimouni M, Gdalevich M. Does breastfeeding protect against allergic rhinitis during childhood? A meta-analysis of prospective studies Acta Paediatr 2002;91:275-279.
201. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-520.
202. Penders J, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 2007;56:661-667.
203. Ramduth D, et al. Detection of HIV type 1 gag-specific CD4(+) T cell responses in acutely infected infants. AIDS Res Hum Retroviruses 2008;24:265-270.
204. Luzuriaga K, et al. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses. J Virol 2000;74:6984-6991.
205. Thobakgale CF, et al. Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants. J Virol 2007;81:12775-12784.
206. Lohman BL, et al. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J Virol 2005;79:8121-8130.
207. Sandberg JK, et al. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol 2003;170:4403-4410.
208. Pugatch D, Sullivan JL, Pikora CA, Luzuriaga K. Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study. J Infect Dis 1997;176:643-648.
209. Ziegner U, Campbell D, Weinhold K, Frank I, Rutstein R, Starr SE. Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection. Clin Diagnost Lab Immunol 1999;6:718-724.
210. Farquhar C, John-Stewart G. The role of infant immune responses and genetic factors in preventing HIV-1 acquisition and disease progression. Clin Exp Immunol 2003;134:367-377.
211. Shalekoff S, Gray GE, Tiemessen CT. Age-related changes in expression of CXCR4 and CCR5 on peripheral blood leukocytes from uninfected infants born to human immunodeficiency virus type 1-infected mothers. Clin Diagnost Lab Immunol 2004;11:229-234.
212. Tuttle DL, Coberley CR, Xie X, Kou ZC, Sleasman JW, Goodenow MM. Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents. AIDS Res Hum Retroviruses 2004;20:305-313.
213. Veazey RS, Lackner AA. HIV swiftly guts the immune system. Nat Med 2005;11:469-470.
214. Brenchley JM, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004;200:749-759.
215. Mehandru S, Dandekar S. Role of the gastrointestinal tract in establishing infection in primates and humans. Curr Opin HIV AIDS 2008;3:22-27.
216. Mehandru S, et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 2004;200:761-770.
217. Favre D, et al. Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection. PLoS Pathog 2009;5:e1000295.
218. Raffatellu M, et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 2008;14:421-428.
219. Wang X, Das A, Lackner AA, Veazey RS, Pahar B. Intestinal double-positive CD4+CD8+ T cells of neonatal rhesus macaques are proliferating, activated memory cells and primary targets for SIVMAC251 infection. Blood 2008;112:4981-4990.
220. Wang X, et al. Simian immunodeficiency virus selectively infects proliferating CD4+ T cells in neonatal rhesus macaques. Blood 2010;116:4168-4174.
221. Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: a possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci USA 2000;97:6043-6048.
222. Siberry GK, et al. Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents. Clin Immunol 2012;142:201-208.
223. Foster SB, et al. Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. J Allergy Clin Immunol 2008;122:159-165.
224. Papasavvas E, et al. Increased microbial translocation in
225. Wallet MA, et al. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS 2010;24:1281-1290.
226. Tozzi AE, Pezzotti P, Greco D. Does breast-feeding delay progression to AIDS in HIV-infected children? AIDS 1990;4:1293-1294.
227. Kafulafula G, et al. Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi. J Acquir Immune Defic Syndr 2010;53:6-13.
228. Taha TE, et al. Effects of cessation of breastfeeding in HIV-1-exposed, uninfected children in Malawi. Clin Infect Dis 2011;53:388-395.
229. Onyango-Makumbi C, et al. Early weaning of HIV-exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV prevention trials in Kampala, Uganda. J Acquir Immune Defic Syndr 2010;53:20-27.
230. Homsy J, et al. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr 2010;53:28-35.
231. Kagaayi J, et al. Survival of infants born to HIV-positive mothers by feeding modality in Rakai, Uganda. PLoS ONE 2008;3:e3877. doi: 3810.1371/journal.pone.0003877
232. Nduati R, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000;283:1167-1174.
233. Thior I, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006;296:794-805.
234. Kuhn L, et al. Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers. Clin Infect Dis 2010;50:437-444.
235. Kuhn L, et al. Differential effects of early weaning for HIV-free survival of children born to HIV-infected mothers by severity of maternal disease. PLoS ONE 2009;4:e6059.
236. Harris JR, et al. Effect of a point-of-use water treatment and safe water storage intervention on diarrhea in infants of HIV-infected mothers. J Infect Dis 2009;200:1186-1193.
237. Becquet R, et al. Two-year morbidity-mortality and alternatives to prolonged breast-feeding among children born to HIV-infected mothers in Cote d'Ivoire. PLoS Med 2007;4:e17.
238. Doherty T, Chopra M, Jackson D, Goga A, Colvin M, Persson LA. Effectiveness of the WHO/UNICEF guidelines on infant feeding for HIV-positive women: results from a prospective cohort study in South Africa. AIDS 2007;21:1791-1797.
239. Peltier CA, et al. Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 2009;23:2415-2423.
240. Nyandiko WM, et al. Outcomes of HIV-exposed children in western Kenya: efficacy of prevention of mother to child transmission in a resource-constrained setting. J Acquir Immun Defic Syndr 2010;54:42-50.
241. Phadke MA, et al. Replacement-fed infants born to HIV-infected mothers in India have a high early postpartum rate of hospitalization. J Nutr 2003;133:3153-3157.
242. Taha TE, et al. The impact of breastfeeding on the health of HIV-positive mothers and their children in sub-Saharan Africa. Bull World Health Organization 2006;84:546-554.
243. Creek TL, et al. Hospitalization and mortality among primarily nonbreastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006. J Acquir Immun Defic Syndr 2010;53:14-19.
244. Kuhn L, Aldrovandi G. Pendulum swings in HIV-1 and infant feeding policies: now halfway back. Adv Exp Med Biol 2012;743:273-287.
245. Brahmbhatt H, et al. Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda. J Acquir Immun Defic Syndr 2006;41:504-508.
246. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004;364:1236-1243.
247. Chatterjee A, Bosch RJ, Hunter DJ, Fataki MR, Msamanga GI, Fawzi WW. Maternal disease stage and child undernutrition in relation to mortality among children born to HIV-infected women in Tanzania. J Acquir Immun Defic Syndr 2007;46:599-606.
248. Gichuhi C, et al. Predictors of mortality in HIV-1 exposed uninfected post-neonatal infants at the Kenyatta National Hospital. Nairobi. East African Med J 2005;82:447-451.
249. Chilongozi D, et al. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania. Ped Infect Dis J 2008;27:808-814.
250. Shapiro RL, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis 2007;196:562-569.
251. Castelletti E, et al. The mucosae-associated epithelial chemokine (MEC/CCL28) modulates immunity in HIV infection. PLoS ONE 2007;2:e969.
252. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet Infect Dis 2012;12:330-340.
253. Kuhn L, Thea DM, Aldrovandi GM. Bystander effects: children who escape infection but not harm. J Acquir Immun Defic Syndr 2007;46:517-518.
254. Hygino J, et al. Altered immunological reactivity in HIV-1-exposed uninfected neonates. Clin Immunol 2008;127:340-347.
255. Chougnet C, et al. Influence of human immunodeficiency virus-infected maternal environment on development of infant interleukin-12 production. J Infect Dis 2000;181:1590-1597.
256. Epalza C, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010;126:e631-638.
257. Miyamoto M, et al. Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents. J Trop Ped 2010;56:427-432.
258. Ono E, et al. Imbalance of naive and memory T lymphocytes with sustained high cellular activation during the first year of life from uninfected children born to HIV-1-infected mothers on HAART. Brazilian J Med Biol Res 2008;41:700-708.
259. Slogrove AL, Cotton MF, Esser MM. Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency. J Trop Ped 2010;56:75-81.
260. Van Rie A, et al. Gamma interferon production in response to Mycobacterium bovis BCG and Mycobacterium tuberculosis antigens in infants born to human immunodeficiency virus-infected mothers. Clin Vaccine Immunol 2006;13:246-252.
261. Gesner M, et al. Alteration in the proportion of CD4 T lymphocytes in a subgroup of human immunodeficiency virus-exposed-uninfected children. Pediatrics 1994;93:624-630.
262. Nielsen SD, et al. Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts. Blood 2001;98:398-404.
263. Clerici M, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000;96:3866-3871.
264. Rich KC, Siegel JN, Jennings C, Rydman RJ, Landay AL. Function and phenotype of immature CD4+ lymphocytes in healthy infants and early lymphocyte activation in uninfected infants of human immunodeficiency virus-infected mothers. Clin Diagnost Lab Immunol 1997;4:358-361.
265. Economides A, Schmid I, Anisman-Posner DJ, Plaeger S, Bryson YJ, Uittenbogaart CH. Apoptosis in cord blood T lymphocytes from infants of human immunodeficiency virus-infected mothers. Clin Diagnost Lab Immunol 1998;5:230-234.
266. Miles DJ, Gadama L, Gumbi A, Nyalo F, Makanani B, Heyderman RS. Human immunodeficiency virus (HIV) infection during pregnancy induces CD4 T-cell differentiation and modulates responses to Bacille Calmette-Guerin (BCG) vaccine in HIV-uninfected infants. Immunology 2010;129:446-454.
267. Harari A, Petitpierre S, Vallelian F, Pantaleo G. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 2004;103:966-972.
268. Velilla PA, Montoya CJ, Hoyos A, Moreno ME, Chougnet C, Rugeles MT. Effect of intrauterine HIV-1 exposure on the frequency and function of uninfected newborns' dendritic cells. Clin Immunol 2008;126:243-250.
269. Embree J, et al. Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi. Ped Infect Dis J 2001;20:397-403.
270. Kuhn L, et al. Interferon-gamma and interleukin-10 production among HIV-1-infected and uninfected infants of HIV-1-infected mothers. Ped Res 2001;50:412-416.
271. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011;305:576-584.
272. Mansoor N, et al. HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guerin vaccine. J Infect Dis 2009;199:982-990.
273. Helfand RF, et al. Evaluation of the immune response to a 2-dose measles vaccination schedule administered at 6 and 9 months of age to HIV-infected and HIV-uninfected children in Malawi. J Infect Dis 2008;198:1457-1465.
274. Abramczuk BM, et al. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol 2011;18:1406-1409.
275. Mazzola TN, et al. Impaired Bacillus Calmette-Guerin cellular immune response in HIV-exposed, uninfected infants. AIDS 2011;25:2079-2087.
276. de Moraes-Pinto MI, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996;173:1077-1084.
277. Farquhar C, et al. High maternal HIV-1 viral load during pregnancy is associated with reduced placental transfer of measles IgG antibody. J Acquir Immun Defic Syndr 2005;40:494-497.
278. Kuhn L, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis 2005;41:1654-1661.
279. Thea DM, et al. A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants. N Engl J Med 1993;329:1696-1702.
280. McNally LM, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet 2007;369:1440-1451.
281. Heresi GP, Caceres E, Atkins JT, Reuben J, Doyle M. Pneumocystis carinii pneumonia in infants who were exposed to human immunodeficiency virus but were not infected: an exception to the AIDS surveillance case definition. Clin Infect Dis 1997;25:739-740.
282. Mussi-Pinhata MM, et al. Lower respiratory tract infections among human immunodeficiency virus-exposed, uninfected infants. Int J Infect Dis 2010;14(Suppl):e176-182.
283. Mussi-Pinhata MM, et al. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Pediatrics 2007;119:e694-704.
284. Bamji M, et al. Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. The New York City Perinatal HIV Transmission Collaborative Study Group. Ped Infect Dis J 1996;15:891-898.
285. Paul ME, et al. Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study. Ped Infect Dis J 2005;24:46-56.
286. Lepage P, et al. Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. Ped Infect Dis J 1996;15:479-485.
287. Ndirangu J, et al. Treating HIV infected mothers reduces mortality in children under 5 years of age to levels seen in children of HIV uninfected mothers: evidence from rural South Africa. Antivir Ther 2012;17:81-90.
288. De Milito A, Morch C, Sonnerborg A, Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 2001;15:957-964.
289. Keating SM, et al. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. AIDS 2011;25:1823-1832.
290. Jacobson MA, Khayam-Bashi H, Martin JN, Black D, Ng V. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function. J Acquir Immun Defic Syndr 2002;31:472-477.
291. Redgrave BE, Stone SF, French MA, Krueger R, James IR, Price P. The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients. HIV Med 2005;6:307-312.
292. Klugman KP, Madhi SA, Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis 2007;20:11-15.
293. Harries AD, et al. The HIV-associated tuberculosis epidemic-when will we act? Lancet 2010;375:1906-1919.
294. O'Brien KL, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009;374:893-902.
295. Mathers C, Fat DM, Boerma JT, World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: World Health Organization, 2008.
296. Perez-Velez CM, Marais BJ. Tuberculosis in children. N Engl J Med 2012;367:348-361.
297. Regidor DL, et al. Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS 2011;25:303-314.
298. Abel K. The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies. Curr HIV Res 2009;7:2-11.
299. Abel K, et al. Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses. J Virol 2006;80:6357-6367.
300. Amedee AM, Lacour N, Ratterree M. Mother-to-infant transmission of SIV via breast-feeding in rhesus macaques. J Med Primatol 2003;32:187-193.
301. Amedee AM, Rychert J, Lacour N, Fresh L, Ratterree M. Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques. Retrovirology 2004;1:17.
302. Davison-Fairburn B, et al. Experimental infection of timed-pregnant rhesus monkeys with simian immunodeficiency virus (SIV) during early, middle, and late gestation. J Med Primatol 1990;19:381-393.
303. Jayaraman P, et al. Perinatal transmission of SHIV-SF162P3 in Macaca nemestrina. J Med Primatol 2004;33:243-250.
304. Marthas ML, et al. Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques. J Virol 1995;69:4198-4205.
305. McClure HM, Anderson DC, Ansari AA, Klumpp SA. The simian immunodeficiency virus infected macaque: a model for pediatric AIDS. Pathologie-Biologie 1992;40:694-700.
306. McClure HM, et al. Maternal transmission of SIVsmm in rhesus macaques. J Med Primatol 1991;20:182-187.
307. Ochs HD, et al. Intra-amniotic inoculation of pigtailed macaque (Macaca nemestrina) fetuses with SIV and HIV-1. J Med Primatol 1993;22:162-168.
308. Jayaraman P, et al. Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3. J Virol 2007;81:822-834.
309. Hartigan-O'Connor DJ, Abel K, McCune JM. Suppression of SIV-specific CD4+ T cells by infant but not adult macaque regulatory T cells: implications for SIV disease progression. J Exp Med 2007;204:2679-2692.
310. Ortiz AM, et al. Depletion of CD4(+) T cells abrogates post-peak decline of viremia in SIV-infected rhesus macaques. J Clin Invest 2011;121:4433-4445.
311. Wang X, et al. Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection. Blood 2007;109:1174-1181.
312. Milush JM, et al. Rapid dissemination of SIV following oral inoculation. AIDS 2004;18:2371-2380.
313. Veazey RS, Lifson JD, Pandrea I, Purcell J, Piatak M Jr, Lackner AA. Simian immunodeficiency virus infection in neonatal macaques. J Virol 2003;77:8783-8792.
314. McChesney MB, et al. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 1998;72:10029-10035.
315. Trivedi P, et al. Intrarectal transmission of simian immunodeficiency virus in rhesus macaques: selective amplification and host responses to transient or persistent viremia. J Virol 1996;70:6876-6883.
316. Van Rompay KK, et al. Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis 1998;177:1247-1259.
317. Persaud D, et al. Functional HIV Cure after Very Early Antiretroviral Therapy of an Infected Infant. 2013 Conference on Retroviruses and Opportunistic Infections, March 3-6, 2013. Atlanta, GA, 2013.
318. Silvestri G, et al. Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003;18:441-452.
319. Apetrei C, et al. Immunovirological analyses of chronically simian immunodeficiency virus SIVmnd-1- and SIVmnd-2-infected mandrills (Mandrillus sphinx). J Virol 2011;85:13077-13087.
320. Goldstein S, et al. Comparison of simian immunodeficiency virus SIVagmVer replication and CD4+ T-cell dynamics in vervet and sabaeus African green monkeys. J Virol 2006;80:4868-4877.
321. Rey-Cuille MA, et al. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J Virol 1998;72:3872-3886.
322. Pandrea I, et al. Simian immunodeficiency viruses replication dynamics in African non-human primate hosts: common patterns and species-specific differences. J Med Primatol 2006;35:194-201.
323. Worobey M, et al. Island biogeography reveals the deep history of SIV. Science 2010;329:1487.
324. VandeWoude S, Apetrei C. Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Med 2006;19:728-762.
325. Pandrea I, et al. Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding. J Virol 2008;82:5501-5509.
326. Chahroudi A, Meeker T, Lawson B, Ratcliffe S, Else J, Silvestri G. Mother-to-infant transmission of simian immunodeficiency virus is rare in sooty mangabeys and is associated with low viremia. J Virol 2011;85:5757-5763.
327. Otsyula MG, Gettie A, Suleman M, Tarara R, Mohamed I, Marx P. Apparent lack of vertical transmission of simian immunodeficiency virus (SIV) in naturally infected African green monkeys. Cercopithecus aethiops. Ann Trop Med Parasitol 1995;89:573-576.
328. Violari A, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med 2008;359:2233-2244.
329. Essajee SM, et al. Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. AIDS 1999;13:2523-2532.
330. Ghaffari G, Passalacqua DJ, Caicedo JL, Goodenow MM, Sleasman JW. Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy. Pediatrics 2004;114:e604-611.
331. Soh CH, et al. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet 2003;362:2045-2051.
332. Walker AS, Doerholt K, Sharland M, Gibb DM. Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. AIDS 2004;18:1915-1924.
333. Weinberg A, et al. Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy. AIDS 2008;22:2267-2277.
334. Resino S, Seoane E, Perez A, Ruiz-Mateos E, Leal M, Munoz-Fernandez MA. Different profiles of immune reconstitution in children and adults with HIV-infection after highly active antiretroviral therapy. BMC Infect Dis 2006;6:112.
335. Luzuriaga K, McManus M, Mofenson L, Britto P, Graham B, Sullivan JL. A trial of three antiretroviral regimens in HIV-1-infected children. N Engl J Med 2004;350:2471-2480.
336. Feeney ME, et al. Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection. J Immunol 2003;171:6968-6975.
337. Lee JC, et al. Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy. AIDS 2006;20:667-674.
338. Mackall CL, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995;332:143-149.
339. Shiau S, et al. Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus. J Ped 2013; doi: 10.1016/j.jpeds.2012.11.025.
340. Laughton B, et al. Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS 2012;26:1685-1690.
341. Penazzato M, Prendergast A, Tierney J, Cotton M, Gibb D. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age. Cochrane Database Syst Rev 2012;7:CD004772.
342. Wamalwa D, et al. Survival benefit of early infant antiretroviral therapy is compromised when diagnosis is delayed. Ped Infect Dis J 2012;31:729-731.
343. Goetghebuer T, et al. Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Clin Infect Dis 2012;54:878-881.
344. Goetghebuer T, et al. Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS 2009;23:597-604.
345. Puthanakit T, et al. Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial. Lancet Infect Dis 2012;12:933-941.
346. Puthanakit T, et al. Cognitive function and neurodevelopmental outcomes in HIV-infected children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Ped Infect Dis J 2013;32:501-508.
347. Archin NM, et al. Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci USA 2012;109:9523-9528.
348. Holte SE, Melvin AJ, Mullins JI, Tobin NH, Frenkel LM. Density-dependent decay in HIV-1 dynamics. J Acquir Immun Defic Syndr 2006;41:266-276.
349. Siliciano JD, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 2003;9:727-728.
350. Ramratnam B, et al. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med 2000;6:82-85.
351. Finzi D, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999;5:512-517.
352. Finzi D, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278:1295-1300.
353. Blankson JN, Persaud D, Siliciano RF. The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med 2002;53:557-593.
354. Persaud D, et al. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children. J Clin Invest 2000;105:995-1003.
355. Ruff CT, et al. Persistence of wild-type virus and lack of temporal structure in the latent reservoir for human immunodeficiency virus type 1 in pediatric patients with extensive antiretroviral exposure. J Virol 2002;76:9481-9492.
356. Persaud D, et al. Dynamics of the resting CD4(+) T-cell latent HIV reservoir in infants initiating HAART less than 6 months of age. AIDS 2012;26:1483-1490.
357. Luzuriaga K, et al. Absent HIV-Specific Immune Responses and Replication-Competent HIV- Reservoirs in Perinatally-Infected Youth treated from Infancy: Towards Cure. 2013 Conference on Retroviruses and Opportunistic Infections, March 3-6. Atlanta, GA, 2013.
358. Van Rompay KK, et al. Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal. Retrovirology 2012;9:57.
359. Frenkel LM, et al. Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science 1998;280:1073-1077.
360. Hartigan-O'Connor DJ, Abel K, Van Rompay KK, Kanwar B, McCune JM. SIV replication in the infected rhesus macaque is limited by the size of the preexisting TH17 cell compartment. Sci Trans Med 2012;4:136ra69.
361. Le T, et al. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med 2013;368:218-230.
362. Fidler S, et al. Short-course antiretroviral therapy in primary HIV infection. N Engl J Med 2013;368:207-217.
363. Deeks SG, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 2012;12:607-614.
364. Magder LS, et al. Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immun Defic Syndr 2005;38:87-95.
365. Mofenson LM, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999;341:385-393.
366. Bulterys PL, et al. Placental malaria and mother-to-child transmission of human immunodeficiency virus-1 in rural Rwanda. Am J Trop Med Hygeine 2011;85:202-206.
367. Panther LA, Tucker L, Xu C, Tuomala RE, Mullins JI, Anderson DJ. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. J Infect Dis 2000;181:555-563.
368. Ricci E, et al. Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1. J Trans Med 2010;8:49.
369. Torres G, Garcia V, Sanchez E, Segarra A, Patterson BK, Melendez-Guerrero LM. Expression of the HIV-1 co-receptors CCR5 and CXCR4 on placental macrophages and the effect of IL-10 on their expression. Placenta 2001;22(Suppl):S29-33.
370. Henrick BM, Nag K, Yao XD, Drannik AG, Aldrovandi GM, Rosenthal KL. Milk matters: soluble Toll-like receptor 2 (sTLR2) in breast milk significantly inhibits HIV-1 infection and inflammation. PLoS ONE 2012;7:e40138.
371. Spector SA. Mother-to-infant transmission of HIV-1: the placenta fights back. J Clin Invest 2001;107:267-269.
372. Ricci E, Malacrida S, Zanchetta M, Montagna M, Giaquinto C, De Rossi A. Role of beta-defensin-1 polymorphisms in mother-to-child transmission of HIV-1. J Acquir Immun Defic Syndr 2009;51:13-19.